Teleflex (TFX) closed at $156.33 on November 11, 2026, up 0.7% from the previous close, on volume of 551,364 shares (30-day average 747,286).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 4, 2026 | Seagull With Put Spread | 20-Nov-26130 P : 145 P : 165 C | 1,350 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
Teleflex to Present at the Jefferies Global Healthcare Conference in London
Business Wire (Wed, 11-Nov 6:30 AM ET)
Teleflex (TFX) Receives a Buy from Bank of America Securities
TipRanks (Sat, 7-Nov 12:36 AM ET)
Teleflex (TFX) Gets a Buy from BMO Capital
TipRanks (Fri, 6-Nov 9:36 AM ET)
Wells Fargo Sticks to Their Hold Rating for Teleflex (TFX)
TipRanks (Fri, 6-Nov 9:35 AM ET)
Teleflex Announces Quarterly Dividend
Business Wire (Thu, 5-Nov 6:45 AM ET)
Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook
Business Wire (Thu, 5-Nov 6:30 AM ET)
Teleflex Announces FDA Breakthrough Device Designation for Freesolve Resorbable Magnesium Scaffold
Business Wire (Thu, 22-Oct 6:45 AM ET)
Teleflex Announces Third Quarter 2026 Earnings Conference Call Information
Business Wire (Thu, 22-Oct 6:30 AM ET)
Business Wire (Mon, 12-Oct 6:30 AM ET)
Business Wire (Tue, 29-Sep 8:07 AM ET)
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
Teleflex trades on the NYSE stock market under the symbol TFX.
As of November 11, 2026, TFX stock price climbed to $156.33 with 551,364 million shares trading.
TFX has a beta of 0.44, meaning it tends to be less sensitive to market movements. TFX has a correlation of 0.02 to the broad based SPY ETF.
TFX has a market cap of $6.20 billion. This is considered a Mid Cap stock.
Last quarter Teleflex reported $568 million in Revenue and $2.63 earnings per share. This beat revenue expectation by $385,960 and exceeded earnings estimates by $.73.
In the last 3 years, TFX traded as high as $257.85 and as low as $100.18.
The top ETF exchange traded funds that TFX belongs to (by Net Assets): IJR, VTI, VB, VBR, SPSM.
TFX has outperformed the market in the last year with a price return of +46.0% while the SPY ETF gained +12.6%. TFX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +17.8% and +12.5%, respectively, while the SPY returned -1.5% and -1.3%, respectively.
TFX support price is $152.14 and resistance is $158.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TFX shares will trade within this expected range on the day.
